Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy

BACKGROUND: There are limited data regarding the impact of body mass index (BMI) on outcomes in advanced breast cancer, especially in patients treated with endocrine therapy (ET) + cyclin-dependent kinase 4/6 inhibitors. METHODS: A pooled analysis of individual patient-level data from MONARCH 2 and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Natl Cancer Inst
Hauptverfasser: Franzoi, Maria Alice, Eiger, Daniel, Ameye, Lieveke, Ponde, Noam, Caparica, Rafael, De Angelis, Claudia, Brandão, Mariana, Desmedt, Christine, Di Cosimo, Serena, Kotecki, Nuria, Lambertini, Matteo, Awada, Ahmad, Piccart, Martine, de Azambuja, Evandro
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2020
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8023855/
https://ncbi.nlm.nih.gov/pubmed/32750143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa116
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge